Enhancement of dissolution amount and in vivo bioavailability of itraconazole by complexation with β-cyclodextrin using supercritical carbon dioxide
Authors:
- Ali H. Al-MarzouqiAAAli H. Al-Marzouqi
- Baboucarr JobeBJBaboucarr Jobe
- Alaa A. HamzaAHAlaa A. Hamza
- Gaber A. RamadanGRGaber A. Ramadan
- 1 October 2007
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 45 (2) , 243-250
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Solubilizing Excipients in Oral and Injectable FormulationsPharmaceutical Research, 2004
- Effect of cyclodextrins on the physicochemical properties and antimycotic activity of clotrimazoleInternational Journal of Pharmaceutics, 1998
- Effect of cyclodextrin on the pharmacology of antifungal oral azolesAntimicrobial Agents and Chemotherapy, 1992
- Increased Gastric pH and the Bioavailability of Fluconazole and KetoconazoleAnnals of Internal Medicine, 1991
- Pharmaceutical Uses of Cyclodextrins and DerivativesDrug Development and Industrial Pharmacy, 1990
- Treatment of invasive aspergillosis with itraconazoleThe American Journal of Medicine, 1989
- The influence of food on the pharmacokinetics of itraconazole in patients with superficial fungal infectionJournal of the American Academy of Dermatology, 1987
- First International Symposium on Itraconazole: A SummaryClinical Infectious Diseases, 1987
- Pharmacokinetics and dose proportionality of ketoconazole in normal volunteersAntimicrobial Agents and Chemotherapy, 1986
- Itraconazole, a new triazole that is orally active in aspergillosisAntimicrobial Agents and Chemotherapy, 1984